BTIG Maintains Buy on Enovis, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 79.3%

Neg 0% Neu 0% Pos 79.3%

BTIG analyst Ryan Zimmerman maintains Enovis (NYSE:ENOV) with a Buy and raises the price target from $39 to $40.

Comments

No comments yet. Be the first!